Senolytic Treatment With Fisetin Reverses Age‐Related Endothelial Dysfunction Partially Mediated by SASP Factor CXCL12

Documenti analoghi

• Intercompartmental communication in senescence
  di: Krystyna Mazan‐Mamczarz, et al.
  Pubblicazione: (2026)
• Intermittent Supplementation With Fisetin Improves Physical Function and Decreases Cellular Senescence in Skeletal Muscle With Aging: A Comparison to Genetic Clearance of Senescent Cells and Synthetic Senolytic Approaches
  di: Kevin O. Murray, et al.
  Pubblicazione: (2025)
• Understanding the mechanisms linking GDF15 to dementia risk: A translational approach
  di: Cassandra O Blew, et al.
  Pubblicazione: (2025)
• Fisetin as a Blueprint for Senotherapeutic Agents – Elucidating Geroprotective and Senolytic Properties with Molecular Modeling
  di: Maciej Spiegel
  Pubblicazione: (2025)
• Senolytic‐Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers
  di: Utkarsh Tripathi, et al.
  Pubblicazione: (2025)